Other Products — Net revenues

Products & Services · Net revenues

AbbVie Other Products — Net revenues decreased by 6.5% to $617.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.0%, from $752.00M to $617.00M. Over 4 years (FY 2021 to FY 2025), Other Products — Net revenues shows relatively stable performance with a -0.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2025
Rolls up toTotal Revenue

How to read this metric

An increase suggests successful monetization of secondary product lines or growth in non-core business areas, while a decrease may indicate the divestiture or natural decline of legacy products.

Detailed definition

This metric represents the total net revenue generated by product lines or business activities that do not meet the quan...

Peer comparison

Most large-cap pharmaceutical companies report similar 'Other' or 'All Other' segments, typically representing a small single-digit percentage of total corporate revenue.

Metric ID: abbv_segment_all_other_net_revenues

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$640.00M$547.00M$594.00M$1.21B$1.01B$925.00M$992.00M$691.00M$741.00M$782.00M$821.00M$744.00M$810.00M$726.00M$752.00M$747.00M$603.00M$660.00M$617.00M
QoQ Change-14.5%+8.6%+103.9%-16.7%-8.3%+7.2%-30.3%+7.2%+5.5%+5.0%-9.4%+8.9%-10.4%+3.6%-0.7%-19.3%+9.5%-6.5%
YoY Change+57.7%+69.1%+67.0%-42.9%-26.6%-15.5%-17.2%+7.7%+9.3%-7.2%-8.4%+0.4%-25.6%-9.1%-18.0%
Range$547.00M$1.21B
CAGR-0.8%
Avg YoY Growth+2.7%
Median YoY Growth-8.4%

Frequently Asked Questions

What is AbbVie's other products — net revenues?
AbbVie (ABBV) reported other products — net revenues of $617.00M in Q4 2025.
How has AbbVie's other products — net revenues changed year-over-year?
AbbVie's other products — net revenues decreased by 18.0% year-over-year, from $752.00M to $617.00M.
What is the long-term trend for AbbVie's other products — net revenues?
Over 4 years (2021 to 2025), AbbVie's other products — net revenues has grown at a -0.4% compound annual growth rate (CAGR), from $2.67B to $2.63B.
What does other products — net revenues mean?
The total revenue generated by all business activities or product lines that are not reported as individual primary segments.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.